Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVO-HYDROXYZIN 50MG CAPSULE Actual shortage 2017-03-13 2020-02-13 1017
NOVO-HYDROXYZIN 25MG CAPSULE Actual shortage 2017-03-13 2017-10-05 1013
NOVO-HYDROXYZIN 10MG CAPSULE Actual shortage 2017-03-10 2017-10-05 159
NOVO-MYCOPHENOLATE 250MG CAPSULE Resolved 2017-03-14 2017-04-25 2278
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2025-10-01 2025-10-01 268159
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2020-09-24 2020-10-08 124959
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-11-28 2025-05-30 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-17 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-07-29 2025-08-29 263746
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-09-19 2025-12-18 267502
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274590
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274595
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-01-09 2025-11-06 247309
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RASAGILINE 1MG TABLET Reversed 2025-05-28 2025-06-04 258753
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258473
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISPERIDONE 2MG TABLET Reversed 2025-05-28 2025-06-04 258679
TEVA-RISPERIDONE 3MG TABLET Reversed 2025-05-28 2025-06-04 258685
TEVA-RISPERIDONE 1MG TABLET Reversed 2025-05-28 2025-06-04 258673
TEVA-RISPERIDONE 0.25MG TABLET Reversed 2025-05-28 2025-06-04 258711
TEVA-RISPERIDONE 4MG TABLET Reversed 2025-05-28 2025-06-04 258688
TEVA-ROSUVASTATIN 20MG TABLET Reversed 2025-05-28 2025-06-04 258765
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-SPIRONOLACTONE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258486
TEVA-SUCRALFATE 1G TABLET Discontinued 2025-09-02 2025-09-02 266359
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Discontinued 2025-05-28 2025-05-28 258478
TEVA-TECNAL 50MG 330MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258471
TEVA-TECNAL C 1/2 50MG 330MG 30MG 40MG CAPSULE Discontinued 2025-05-28 2025-05-28 258462